JP7295576B2 - インスリン産生細胞 - Google Patents
インスリン産生細胞 Download PDFInfo
- Publication number
- JP7295576B2 JP7295576B2 JP2020549318A JP2020549318A JP7295576B2 JP 7295576 B2 JP7295576 B2 JP 7295576B2 JP 2020549318 A JP2020549318 A JP 2020549318A JP 2020549318 A JP2020549318 A JP 2020549318A JP 7295576 B2 JP7295576 B2 JP 7295576B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- insulin
- group
- positive
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018175465 | 2018-09-19 | ||
| JP2018175465 | 2018-09-19 | ||
| PCT/JP2019/037725 WO2020059892A1 (ja) | 2018-09-19 | 2019-09-18 | インスリン産生細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020059892A1 JPWO2020059892A1 (ja) | 2021-08-30 |
| JPWO2020059892A5 JPWO2020059892A5 (cg-RX-API-DMAC7.html) | 2022-09-13 |
| JP7295576B2 true JP7295576B2 (ja) | 2023-06-21 |
Family
ID=69887298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020549318A Active JP7295576B2 (ja) | 2018-09-19 | 2019-09-18 | インスリン産生細胞 |
Country Status (14)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019169351A1 (en) | 2018-03-02 | 2019-09-06 | Semma Therapeutics, Inc. | Methods of enhancing stem cell differentiation into beta cells |
| CN112912490B (zh) * | 2018-08-03 | 2023-12-26 | 千纸鹤治疗公司 | 细胞制造方法 |
| EP3833365A4 (en) | 2018-08-10 | 2022-05-11 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
| JP7705448B2 (ja) | 2020-07-31 | 2025-07-09 | バーテックス ファーマシューティカルズ インコーポレイテッド | 膵内分泌細胞の分化 |
| CN116391028A (zh) * | 2020-11-20 | 2023-07-04 | 千纸鹤治疗公司 | 促熟剂 |
| TW202246489A (zh) * | 2021-02-09 | 2022-12-01 | 日商千紙鶴治療公司 | 成熟化劑 |
| JP2024542041A (ja) | 2021-11-01 | 2024-11-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | 幹細胞由来の膵臓島分化 |
| IL315122A (en) * | 2022-04-25 | 2024-10-01 | Orizuru Therapeutics Inc | Maturing agent having both of alk5 inhibitory activity and cdk8/19 inhibitory activity |
| EP4596675A4 (en) | 2022-09-26 | 2026-03-11 | Univ Kyoto | PROCESS FOR THE PRODUCTION OF PANCREATIC ENDODERMAL CELLS |
| EP4753734A1 (en) * | 2023-08-02 | 2026-06-10 | Joslin Diabetes Center, Inc. | Ribosomal remodeling in diabetes |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009528066A (ja) | 2006-03-02 | 2009-08-06 | サイセラ,インコーポレイテッド | 内分泌前駆細胞、膵臓ホルモン発現細胞及びそれらの製造方法 |
| JP2014501518A (ja) | 2010-12-08 | 2014-01-23 | ヴィアサイト,インコーポレイテッド | ヒト万能性幹細胞の成長を阻害する薬剤および方法 |
| WO2019208505A1 (ja) | 2018-04-23 | 2019-10-31 | 国立大学法人京都大学 | 増殖抑制剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005096873A1 (de) | 2004-04-10 | 2005-10-20 | Henkel Kommanditgesellschaft Auf Aktien | Lockenwickler |
| EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| US7661738B2 (en) | 2006-11-28 | 2010-02-16 | Veritainer Corporation | Radiation detection unit for mounting a radiation sensor to a container crane |
| MX348010B (es) | 2007-04-07 | 2017-05-23 | Whitehead Inst Biomedical Res | Reprogramacion de celulas somaticas. |
| JP2010528622A (ja) | 2007-05-30 | 2010-08-26 | ザ ジェネラル ホスピタル コーポレイション | 体細胞から多能性細胞を生成する方法 |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| WO2009012428A2 (en) | 2007-07-18 | 2009-01-22 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| US9446168B2 (en) | 2010-06-07 | 2016-09-20 | Beta-O2 Technologies Ltd. | Multiple-layer immune barrier for donor cells |
| US9540630B2 (en) | 2008-09-17 | 2017-01-10 | Beta O2 Technologies Ltd. | Optimization of alginate encapsulation of islets for transplantation |
| US20120270890A1 (en) * | 2011-04-22 | 2012-10-25 | Cheng-Ho Chung | Methods of Pancreatic Beta Cell Regeneration |
| RU2705001C2 (ru) * | 2011-12-22 | 2019-11-01 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
| IL321825A (en) * | 2013-02-06 | 2025-08-01 | Viacyte Inc | Cell compositions derived from dedifferentiated reprogrammed cells |
| WO2015002888A1 (en) * | 2013-07-01 | 2015-01-08 | Trustees Of Boston University | Dissolvable hydrogel compositions for wound management and methods of use |
| SG11201700874SA (en) | 2014-08-04 | 2017-03-30 | Takeda Pharmaceuticals Co | Method for proliferation of pancreatic progenitor cells |
| CN107250349A (zh) * | 2014-12-19 | 2017-10-13 | 詹森生物科技公司 | 多能干细胞的悬浮培养 |
| HK1254740A1 (zh) * | 2015-11-30 | 2019-07-26 | Kadimastem Ltd. | 分化和纯化胰腺内分泌细胞的方法 |
| MA45329A (fr) * | 2016-04-08 | 2019-02-13 | Univ California | Production de cellules bêta matures pleinement fonctionnelles à partir de progénitrices pancréatiques humaines |
| JP6863805B2 (ja) | 2017-04-14 | 2021-04-21 | グローリー株式会社 | 各台装置及び各台装置制御方法 |
-
2019
- 2019-09-18 TW TW108133603A patent/TWI862513B/zh active
- 2019-09-18 EP EP19863748.0A patent/EP3854869A4/en active Pending
- 2019-09-18 CN CN201980061019.8A patent/CN112867787B/zh active Active
- 2019-09-18 US US17/277,406 patent/US20210353686A1/en active Pending
- 2019-09-18 BR BR112021004815-4A patent/BR112021004815A2/pt unknown
- 2019-09-18 CA CA3113608A patent/CA3113608A1/en active Pending
- 2019-09-18 SG SG11202102748WA patent/SG11202102748WA/en unknown
- 2019-09-18 WO PCT/JP2019/037725 patent/WO2020059892A1/ja not_active Ceased
- 2019-09-18 KR KR1020217006143A patent/KR102892433B1/ko active Active
- 2019-09-18 MX MX2021003147A patent/MX2021003147A/es unknown
- 2019-09-18 IL IL281531A patent/IL281531B2/en unknown
- 2019-09-18 JP JP2020549318A patent/JP7295576B2/ja active Active
- 2019-09-18 AU AU2019343003A patent/AU2019343003B2/en active Active
-
2021
- 2021-03-29 CO CONC2021/0003947A patent/CO2021003947A2/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009528066A (ja) | 2006-03-02 | 2009-08-06 | サイセラ,インコーポレイテッド | 内分泌前駆細胞、膵臓ホルモン発現細胞及びそれらの製造方法 |
| JP2014501518A (ja) | 2010-12-08 | 2014-01-23 | ヴィアサイト,インコーポレイテッド | ヒト万能性幹細胞の成長を阻害する薬剤および方法 |
| WO2019208505A1 (ja) | 2018-04-23 | 2019-10-31 | 国立大学法人京都大学 | 増殖抑制剤 |
Non-Patent Citations (7)
| Title |
|---|
| Diabetologia,2012年,vol. 55, [Suppl1],p. S178-S179,Abstract Number: 420 |
| PAGLIUCA, F.W. et al.,Generation of Functional Human Pancreatic β Cells In Vitro,Cell,2014年10月09日,vol. 159,p. 428-439 |
| REZANIA, Alireza et al.,Enrichment of Human Embryonic Stem Cell-Derived NKX6.1-Expressing Pancreatic Progenitor Cells Accelerates the Maturation of Insulin-Secreting Cells In Vivo,STEM CELL,2013年,vol. 31,p. 2432-2442 |
| REZANIA, Alireza et al.,Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells,Nature Biotechnology,2014年,vol. 32, no. 11,p. 1121-1133, Online Methods,,Supplementary information p. 1-38 |
| RICHARDSON, Thomas, et al.,Alginate Encapsulation of Human Embryonic Stem Cells to Enhance Directed Differentiation to Pancreatic Islet-Like Cells,Tissue Engineering: Part A,2014年,Vol. 20, No. 23 and 24,p. 3198-3211 |
| ROBERT, Thomas et al.,Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control,Stem Cell Reports,2018年03月13日,vol. 10,p. 739-750 |
| YAMASHITA-SUGAHARA, Y. et al.,Scientific Reports,6: 35908 (2016) |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019343003A1 (en) | 2021-05-13 |
| CN112867787B (zh) | 2024-11-22 |
| IL281531B1 (en) | 2024-11-01 |
| KR20210060446A (ko) | 2021-05-26 |
| BR112021004815A2 (pt) | 2021-06-01 |
| IL281531A (en) | 2021-05-31 |
| TW202026420A (zh) | 2020-07-16 |
| MX2021003147A (es) | 2021-05-14 |
| WO2020059892A1 (ja) | 2020-03-26 |
| IL281531B2 (en) | 2025-03-01 |
| SG11202102748WA (en) | 2021-04-29 |
| CA3113608A1 (en) | 2020-03-26 |
| EP3854869A4 (en) | 2022-09-07 |
| CO2021003947A2 (es) | 2021-04-19 |
| CN112867787A (zh) | 2021-05-28 |
| TWI862513B (zh) | 2024-11-21 |
| US20210353686A1 (en) | 2021-11-18 |
| JPWO2020059892A1 (ja) | 2021-08-30 |
| KR102892433B1 (ko) | 2025-11-27 |
| EP3854869A1 (en) | 2021-07-28 |
| AU2019343003B2 (en) | 2025-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102892433B1 (ko) | 인슐린 산생 세포 | |
| US20190390169A1 (en) | Pancreatic progenitor cell production method | |
| JP6779509B2 (ja) | 増殖抑制剤 | |
| JP2025000878A (ja) | 生体組織様構造体の製造方法 | |
| ES3026932T3 (en) | Cell production method | |
| RU2829220C2 (ru) | Инсулинпродуцирующие клетки | |
| RU2825665C2 (ru) | Ингибитор роста | |
| WO2022172960A1 (ja) | 成熟化剤 | |
| JPWO2017188082A1 (ja) | 培地添加剤 | |
| WO2023210578A1 (ja) | Alk5阻害活性とcdk8/19阻害活性とを有する成熟化剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20211026 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220905 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220905 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220907 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221018 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221027 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230309 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20230309 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20230316 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20230328 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230523 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230602 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7295576 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |